-
The State Food and Drug Administration investigated the quality and safety supervision of color contact lenses
Time of Update: 2022-09-07
drug Xu Jinghe pointed out that color contact lenses belong to the third class of medical devices with high risk, and according to the regulations on the supervision and administration of medical devices, they belong to products that "require special measures to be strictly controlled and managed".
-
Walking at the grassroots level into the enterprise Zhang Wei, president of the China Drug Supervision and Administration Research Association, and his party came to Qianhui for research and guidance
Time of Update: 2022-09-07
On the afternoon of August 19, 2022, Zhang Wei, president of the China Drug Administration and Research Association and former secretary general of the State Pharmacopoeia Commission, Shi Liqiang, vi
-
National Medical Insurance Bureau: In the first seven months of the country, outpatient expenses were directly settled across provinces by 14.0422 million person-times
Time of Update: 2022-09-07
In order to facilitate the insured to directly settle the treatment costs related to 5 kinds of outpatient chronic and special diseases across provinces, the APP of the national medical insurance service platform has added query functions such as the notification letter of inter-provincial outpatient chronic and special diseases .
-
A large number of pharmaceutical companies want to take advantage of this model to achieve "curve overtaking" on the innovative drug track
Time of Update: 2022-09-07
License-in is a popular equity trading model in the domestic biomedical industry in recent years, and the reason why it is sought after by pharmaceutical companies is mainly because on the high-risk and high-input innovative drug track, this is a shortcut with less investment, fast effect, and even "curve overtaking".
-
Interpreting the pattern of the children's drug market, the track overtaking focuses on the segmentation
Time of Update: 2022-09-07
Kinsey's pediatric drugs are not used in the two major disease areas of breathing and digestion, and its core products are recombinant human growth hormone for childhood short stature, which extends the layout of height management, sexual development, newborns, child care, children's neuropsychiatric and other fields.
-
Looking for good medicine, talking about classics, Zhong Jing explained the final list of classic ambassadors in three minutes!
Time of Update: 2022-09-07
Thirty-seven elites gathered in Xixia, Henan Province, where they talked about classic and famous prescriptions at the Medical Saint Herbs Collection Office, and competed fiercely for the final qualification of the event!Enrich the schedule to help professional improvementLin Jingwei, a star lecturer of Zhongjing Academy, brought professional courses to the players in the semi-finals, introduced a number of classic famous recipes, explained the in-depth and easy-to-understand recipes, and enhanced the players' cognition of classic famous recipes .
-
Circular of the State Food and Drug Administration on The Issuance of the Catalogue of Generic Drug Reference Preparations (Batch 57) (No. 38 [2022])
Time of Update: 2022-09-07
docx After the review and determination of the Expert Committee on the Consistency Evaluation of the Quality and Efficacy of Generic Drugs of the State Drug Administration, the Catalogue of Generic Drug Reference Preparations (The Fifty-seventh Batch) is hereby released.
-
The consolidation of the pharmaceutical market has accelerated, and another pharmaceutical company has sold off hospitals
Time of Update: 2022-09-07
Financial data show that in 2021, Chenwei Zhongde achieved operating income of about 706 million yuan and net profit of 16.
Financial data show that in 2021, Chenwei Zhongde achieved operating income of about 706 million yuan and net profit of 16.
-
Guangxi identified 218 medicines as the first batch of Guangxi ethnic medicines
Time of Update: 2022-09-07
, Ltd. includes Guilong ointment, Guilong medicinal wine, tincture of bruises and sprains, compound Shuanghuateng antipruritic liniment, Tiezhuoqingzhuo Pills, Chuanjin Yigan Tablets, Sanshen Yiqi Oral Liquid, Twelve products, including Longan Qiongyu Granules, Antai Yimu Pills, Kanggongyan Granules, Relieving Cough and Asthma Ointment, and Compound Houttuynia Granules, were recognized as Guangxi ethnic medicines .
-
With the prevention and control of myopia becoming an important part of the national health strategy, the ophthalmology industry will have great prospects
Time of Update: 2022-09-07
In recent years, the development of the ophthalmology industry has begun to accelerate as the people of our country are affected by various factors such as lifestyle changes, the increase in the use of electronic products, and the improper use of eyes .
-
National Medical Insurance Bureau: The focus of the national centralized procurement of high-value consumables is coming
Time of Update: 2022-09-07
On September 3, the National Medical Security Administration made a unified reply to the recommendations of the Fifth Session of the Thirteenth National People's Congress, revealing a lot of first-ha
-
In August, the executives of multinational pharmaceutical companies changed frequently, and companies were in a war for talent!
Time of Update: 2022-09-07
On August 30, AstraZeneca announced the appointment of Liu Ming as Vice President of AstraZeneca China, Head of the Lung Cancer Treatment and Tumor Immunotherapy-related Business Units of the Oncology Division, and joined the Chinese management team to directly report to AstraZeneca’s oncology business.
-
A new round of NRA assessments is complete, and China is playing a more active role in the global vaccine supply
Time of Update: 2022-09-07
The head of the NRA office said: "We will take this assessment as a new starting point, continue to communicate and cooperate closely with the WHO, work together with all relevant departments, continuously improve the ability and level of drug supervision, continue to provide safe and effective, controllable and affordable vaccine drugs for Chinese and the global public, and make greater contributions to the protection and promotion of human health.
-
In August, the organization surveyed 766 companies, and the pharmaceutical industry was focused on
Time of Update: 2022-09-07
In the past August, because of the intensive disclosure of the interim report, enterprises have also been significantly investigated by institutions. According to the data, the institution surveyed 7
-
Domestic pharmaceutical equipment companies are accelerating the road to differentiated innovation!
Time of Update: 2022-09-07
It is reported that at present, there are many domestic pharmaceutical equipment with R&D strength and capital that have been increasing the investment in innovative R&D and carrying out diversified and differentiated innovations in equipment and technology to help pharmaceutical companies develop higher quality .
-
Solicit for special treatment of dental implant medical service charges and consumable prices
Time of Update: 2022-09-07
In order to implement the decisions and arrangements of the Party Central Committee and the State Council, in accordance with the requirements of the "Key Points of Correcting Unhealthy Practices in the Field of Pharmaceutical Purchase and Sales and Medical Services in 2022" jointly issued by nine ministries and commissions, the National Medical Security Administration has formed a plan based on previous investigations and soliciting industry opinions.
-
In 5 years, cross-border transactions between local pharmaceutical companies and overseas pharmaceutical companies increased by 300%
Time of Update: 2022-09-07
On May 5, Lixin Pharmaceutical licensed the innovative antibody-conjugated drug (ADC) LM-302 independently developed by Lixin Pharmaceutical to Turning Point corporation in the United States; On April 6, HeboMed announced that it had entered into a global external licensing agreement with AstraZeneca to develop and commercialize HBM7022.
-
Announcement on the establishment of Shijiazhuang Air Port as a port of import for pharmaceuticals
Time of Update: 2022-09-07
According to the Drug Administration Law of the People's Republic of China, with the approval of the State Council, it was agreed to add Shijiazhuang Air Port as a drug import port. The relevant matt
-
NMPA: 20 batches of drugs are unqualified→ and see foreign bodies visible in injections!
Time of Update: 2022-09-07
On August 29, 2022, the State Food and Drug Administration issued a drug sampling quality announcement, which involved a total of 20 batches of drugs produced by 9 enterprises, of which 2 batches of injection visible foreign bodies did not meet the regulations, 3 batches of chrysanthemums detected banned pesticide residues, 7 batches of comfrey did not meet the regulations, and risk control measures such as suspension of sales and use and recall of the above drugs have been taken.
-
State Food and Drug Administration: Launch electronic payment of registration fees for drugs and medical device products
Time of Update: 2022-09-07
State Food and Drug Administration August 22, 2022 According to the requirements of the Ministry of Finance on steadily promoting the general payment of electronic non-tax income, the State Food and Drug Administration decided to use the electronic payment of registration fees for drugs and medical devices.
